Overview

Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC

Status:
Completed

Trial end date:
2017-12-01

Target enrollment:

Participant gender:

Summary

Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC.

Details

Lead Sponsor:

Grupo Español de Investigación en Cáncer de Ovario

Collaborator:

PharmaMar

Treatments:

Doxorubicin
Liposomal doxorubicin
Trabectedin